(2S,4S)-4-(4-(3-amino-1H-indazol-6-yl)-1H-1,2,3-triazol-1-yl)-N-(4-bromophenyl)pyrrolidine-2-carboxamide

ID: ALA5203678

Chembl Id: CHEMBL5203678

PubChem CID: 168293261

Max Phase: Preclinical

Molecular Formula: C20H19BrN8O

Molecular Weight: 467.33

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1n[nH]c2cc(-c3cn([C@@H]4CN[C@H](C(=O)Nc5ccc(Br)cc5)C4)nn3)ccc12

Standard InChI:  InChI=1S/C20H19BrN8O/c21-12-2-4-13(5-3-12)24-20(30)17-8-14(9-23-17)29-10-18(26-28-29)11-1-6-15-16(7-11)25-27-19(15)22/h1-7,10,14,17,23H,8-9H2,(H,24,30)(H3,22,25,27)/t14-,17-/m0/s1

Standard InChI Key:  HBROJOMCQONOAW-YOEHRIQHSA-N

Alternative Forms

  1. Parent:

    ALA5203678

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562/Adr (229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.33Molecular Weight (Monoisotopic): 466.0865AlogP: 2.71#Rotatable Bonds: 4
Polar Surface Area: 126.54Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.30CX Basic pKa: 9.09CX LogP: 2.62CX LogD: 0.93
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.37Np Likeness Score: -1.42

References

1. Pan X, Liu N, Liu Y, Zhang Q, Wang K, Liu X, Zhang J..  (2022)  Design, synthesis, and biological evaluation of trizole-based heteroaromatic derivatives as Bcr-Abl kinase inhibitors.,  238  [PMID:35561654] [10.1016/j.ejmech.2022.114425]

Source